Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

EVALUATION OF GBV-C/HGV VIREMIA IN HIV-INFECTED WOMEN

Full text
Author(s):
Silva, Synara Araujo [1] ; Rodrigues, Celia Lima [1, 2] ; Campos, Aleia Faustino [1] ; Levi, Jose Eduardo [1, 2]
Total Authors: 4
Affiliation:
[1] Univ Sao Paulo, Sch Med, Dept Infect Dis, BR-05403000 Sao Paulo - Brazil
[2] Univ Sao Paulo, Inst Trop Med, Virol Lab, BR-05403000 Sao Paulo - Brazil
Total Affiliations: 2
Document type: Journal article
Source: Revista do Instituto de Medicina Tropical de São Paulo; v. 54, n. 1, p. 31-35, JAN-FEB 2012.
Web of Science Citations: 2
Abstract

The present study aimed at standardizing a real-time quantitative polymerase chain reaction assay to evaluate the presence of GBV-C/HGV RNA. A ``TaqMan{''} assay using primers and probe derived from the 5' NCR region was developed and validated. Two hundred and fifty-three plasma samples from HIV-infected women were tested for GBV-C viremia and antibody against the envelope protein 2. GBV-C RNA was detected in 22.5% of the patients whereas the antibody was identified in 25.3% of the cohort. Detection of viral RNA and of antibodies was mutually exclusive. Viral loads showed a mean of 1,777 arbitrary units/mL, being 1.1 and 13,625 arbitrary units/mL respectively the lowest and highest values measured. We conclude that the real-time quantitative polymerase chain reaction method developed is appropriate for the investigation of GBV-C RNA since it was shown to be highly specific and sensitive, as well as requiring few steps, preventing contamination and providing additional information as to the relative viremia of carriers, a parameter that must be included in studies evaluating the co-factors influencing the clinical outcome of HIV/AIDS. (AU)

FAPESP's process: 05/01072-9 - GB virus C/HGV and prognosis on HIV infected women
Grantee:José Eduardo Levi
Support Opportunities: Regular Research Grants